 A randomised, double-blind, placebo-controlled, incomplete block, 4-period crossover study to investigate the effects of 5-day repeat inhaled doses of fluticasone propionate BID, 50-2000 mcg on airway responsiveness to adenosine-5-monophosphate AMP challenge when delivered after the last dose in mild asthmatic subjects 